IL6 and metabolic syndrome: A major underlying factor driving the pathogenesis in obesity and metabolic syndrome is the presence of a chronic low-grade inflammation, which is characterized by increased circulating IL-6 and other cytokines, as well as altered levels of adipokines, such as leptin and adiponectin (3, 7–11).